GlassScriptPhysician profile
Peter Grangaard
NPI 1356886733
$2,023.48
in general payments reported to CMS, 2019-2025
19 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.48 · 2023: $268 · 2024: $492 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.01 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $525.58 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $320.11 | 2024-2025 | |
| Janssen Biotech, INC. | $309.90 | 2025 | Tremfya |
| Lilly USA, LLC | $200.92 | 2023-2024 | Taltz |
| Amgen INC. | $158.00 | 2023-2025 | Evenity, Prolia, Tavneos |
| Glaxosmithkline, LLC. | $114.61 | 2024-2025 | Benlysta |
| Radius Health, INC. | $102.44 | 2023-2025 | Tymlos |
| Janssen Scientific Affairs, LLC | $66.81 | 2024 | Tremfya |
| Ucb, INC. | $38.08 | 2023-2024 | Cimzia |
| Sobi, INC | $32.73 | 2024-2025 | |
| Genzyme Corporation | $27.64 | 2025 | |
| Boston Scientific Corporation | $20.04 | 2024 | Intracept |
| Dendreon Pharmaceuticals LLC | $19.48 | 2021 | |
| Fresenius Kabi USA, LLC | $18.36 | 2024 | Idacio |
| Relievant Medsystems, INC. | $17.63 | 2023 | Intracept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alvogen INC | $17.55 | 2025 | Teriparatide |
| Astrazeneca Pharmaceuticals LP | $14.55 | 2024 | Saphnelo |
| Sandoz INC. | $13.10 | 2023 | Hyrimoz |
| Organon LLC | $5.95 | 2025 | Hadlima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Grangaard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.